E. Marwood

AGILE-ACCORD: A Randomized, Multicentre, Seamless, Adaptive Phase I/II Platform Study to Determine the Optimal Dose, Safety and Efficacy of Multiple Candidate Agents for the Treatment of COVID-19: A structured summary of a study protocol for a randomised platform trial

T. Jaki, S. Khoo, S. Ewings, 2020, Trials.

Optimal dose and safety of molnupiravir in patients with early SARS-CoV-2: a Phase I, open-label, dose-escalating, randomized controlled study

W. Greenhalf, T. Jaki, S. Khoo, 2021, The Journal of antimicrobial chemotherapy.

Optimal dose and safety of molnupiravir in patients with early SARS-CoV-2: a phase 1, dose-escalating, randomised controlled study

T. Fletcher, W. Greenhalf, T. Jaki, 2021, medRxiv.

Patient preferences for whole-body MRI or conventional staging pathways in lung and colorectal cancer: a discrete choice experiment

V. Goh, E. Karapanagiotou, S. Punwani, 2019, European Radiology.

Phase I Trial of DNA Methyltransferase Inhibitor Guadecitabine Combined with Cisplatin and Gemcitabine for Solid Malignancies Including Urothelial Carcinoma (SPIRE)

R. Huddart, J. Catto, S. Crabb, 2021, Clinical Cancer Research.

Pan-AKT Inhibitor Capivasertib With Docetaxel and Prednisolone in Metastatic Castration-Resistant Prostate Cancer: A Randomized, Placebo-Controlled Phase II Trial (ProCAID)

V. Khoo, S. Sundar, S Kumar, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed non-small-cell lung cancer : the prospective Streamline L trial

Steve Halligan, Vicky Goh, William Ricketts, 2019 .

Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed colorectal cancer: the prospective Streamline C trial

Steve Halligan, Vicky Goh, William Ricketts, 2019, The lancet. Gastroenterology & hepatology.

PS01.11 Nivolumab Versus Placebo in Relapsed Malignant Mesothelioma: The CONFIRM Phase 3 Trial

C. Richards, D. Fennell, P. Szlosarek, 2021 .

Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed non-small-cell lung cancer: the prospective Streamline L trial

A. Bhowmik, N. Strickland, V. Goh, 2019, The Lancet. Respiratory medicine.